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Abstract 
The aim of this study was to develop a hypothesis to explain the link between HIV prevalence and area of residence. The study was conducted in 
two parts using two existing data sources. In Part 1, the bloodborne viral test status and test results of a sample of clients attending treatment in 
December 2001 in two areas of Dublin, an inner city area (Dublin 8) and a suburban area (Dublin 24), were extracted from the Bloodborne Viral 
Status Dataset created by Grogan. In Part 2 the characteristics of heroin users seeking treatment for the first time at treatment services in their 
respective areas of residence, Dublin 8 or Dublin 24, between 1997 and 2000 were examined, using data from the National Drug Treatment 
Reporting System. A higher proportion of heroin users in Dublin 8 had HIV and hepatitis C than did their counterparts in Dublin 24. The analysis 
suggests that heroin users in Dublin 8 were more likely both to have ever used cocaine and to have used heroin daily, than were those who lived'in 
Dublin 24. Also, a higher proportion of injectors living in Dublin 8 used heroin and cocaine concurrently than did their counterparts in Dublin 24. In 
both samples, heroin users who lived in Dublin 8 were older than those who lived in Dublin 24. The findings led to a hypothesis: 'The risk of acquiring 
HIV is associated with area of residence and may be linked to cocaine use,' 
Introduction 
Canadian researchers have found that the prevalence of HIV among drug 
users is linked to area of residence.1 Between 1985 and 2002, there 
were 3,009 persons in Ireland identified as having antibodies to HIV.2 
Of these, 1,084 (36%) were intravenous drug users. Kelly and Clarke3 
reported a fall in the number of HIV cases among injecting drug users 
between 1994 and 1998, and suggested that this might be attributable 
to the introduction and expansion of harm-reduction measures. However, 
in 1999, there was a sharp increase in the number of injecting drug 
users testing positive for HIV, with 69 new cases; the trend continued 
into 2000 with 83 new cases.2,4'5 Clarke and colleagues6 reviewed the 
demographic data of new HIV-positive cases diagnosed between January 
1999 and December 2000. The authors reported that 40 per cent of 
these cases were less than 22 years old and that there was a clustering 
of cases in the Rialto (Dublin 8) area. The numbers of new injector 
cases in 2001 and 2002 were lower that those in 1999, at 38 and 50 
respectively, but remained higher than in 1998. Grogan and colleagues7 
ascertained the prevalence and incidence of bloodborne viruses among 
heroin users attending methadone treatment services in the HSE South 
Western Area in December 2001 by means of a retrospective review of 
participants' clinical and laboratory records. The researchers observed 
that there was a large pool of HIV-positive cases living in Dublin 8, while 
a smaller number of HIV cases lived in Dublin 24 (Dr E Keenan, personal 
communication, 2003). The authors of the present paper developed a 
hypothesis to explain this observation by examining existing data from 
two sources. 
Methods 
This paper analyses data from two separate samples, both comprising 
heroin users from Dublin 8 and Dublin 24. Dublin 8 is situated close to 
and south of Dublin's inner city, while Dublin 24 is a suburb eight miles 
from the city centre. Both areas contain a number of electoral divisions 
with high levels of deprivation, as well as a number of problem heroin 
users.8 
The first sample was a subset of the Bloodborne Viral Status Dataset 
created by Grogan and colleagues.7 This dataset is a one-in-four 
systematic sample of all clients on the Central Treatment List (a listing of 
clients receiving an opiate substitute held by the Drug Treatment Centre 
Board) who were attending treatment in the HSE South Western Area in 
December 2001. Each record was examined using a checklist to extract 
the bloodborne viral test status. In addition, demographic characteristics 
and treatment characteristics were collected. The data subset used in 
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Part 1 of this study comprised Central Treatment List clients living and 
treated in Dublin 8 and Dublin 24 in December 2001. 
The second sample was a subset of the National Drug Treatment 
Reporting System (NDTRS) population; this database is maintained 
by the Health Research Board. The data collected include treatment-
seeking behaviour, socio-demographic and economic characteristics, 
types of problem drugs used and drug-using behaviours. The data on 
heroin users treated in their respective areas of residence for the first 
time, Dublin 8 or Dublin 24, were extracted for the years 1997 to 2000. 
The characteristics of cases living in Dublin 8 were compared with those 
of cases living in Dublin 24 in an attempt to explain the differences 
in the proportions testing positive for HIV and hepatitis C in the two 
geographical areas. 
The two data sources were used to develop the hypothesis because 
some variables were common to both samples (demographic and 
treatment characteristics) and some were different (drug using 
characteristics in the NDTRS and bloodborne viral status in the 
Bloodborne Viral Status Dataset). The data returned to the NDTRS 
are anonymous, therefore this database could not be merged with the 
Bloodborne Viral Status Dataset in order to link the more extensive 
epidemiological information with the bloodborne viral status information. 
Statistical analyses were carried out using STATA version 7.0 and SPSS 
version 11. A multiple logistic regression model was developed to control 
for confounding and identify effect modification. This model allowed 
comparison of the characteristics associated with heroin users living in 
each area. Exact 95 per cent confidence intervals were calculated for 
proportions testing positive for each infection and for regression adjusted 
odds ratios. 
Results 
The results will be presented in two parts. 
Part 1 
We reviewed the records of 101 clients of treatment centres in Dublin 
8, and those of 64 clients of centres in Dublin 24. The clients attending 
treatment centres in Dublin 8 were older than those treated in Dublin 
24 (Table 1). A higher proportion of male clients attended treatment in 
Dublin 24 than in Dublin 8, at 64.1 per cent versus 52.5 per cent, though 
this was not statistically significant. There was no association between 
the number of months spent in treatment and area of residence. 
In both areas, uptake of testing for HIV, hepatitis B and hepatitis C was 
high (Table 1). Higher proportions tested positive for HIV and hepatitis C 
in Dublin 8 than in Dublin 24. While the differences noted in demographic 
and treatment characteristics by area of residence may explain the higher 
rates of hepatitis C among the cohort treated in Dublin 8, they do not 
fully explain the high number of HIV-positive cases observed in Dublin 8 
compared with Dublin 24. 
Part 2 
In an attempt to explain the excess risk of HIV among those treated in 
Dublin 8 compared to those treated in Dublin 24, data on heroin users 
attending treatment services in their respective areas of residence for the 
first time were analysed, Between 1997 and 2000, problem heroin use 
was reported by 803 first-time attenders at treatment services in Dublin 
8 and Dublin 24. Of these, 501 lived and were treated in Dublin 8, while 
302 lived and were treated in Dublin 24. Of the 803 individuals treated, 
injector status was known for 795 individuals; 624 (78.5%) of the 795 
reported ever injecting. A higher proportion of injectors lived in Dublin 
8 than in Dublin 24: 84.8 per cent (423/499) versus 67.9 per cent 
(201/296) respectively, p value <0.0001. 
After controlling for confounding factors, we examined the characteristics 
associated with heroin users in both areas (Table 2). Heroin users who 
lived in Dublin 8 were five times more likely to report cocaine as a second 
problem drug than those who lived in Dublin 24. They were three times 
more likely to report daily drug use, almost twice as likely to have been 
treated previously elsewhere, 60 per cent less likely to be employed, and 
more likely to be older and female than heroin users living in Dublin 24. 
Injecting drug use was not a significant independent factor once cocaine 
and frequency of heroin use were entered in the model. The use of 
cannabis as a second drug in each of the areas was associated with the 
period of data collection. The reason for this is not clear; it may reflect a 
reporting bias or an actual change in drug-using patterns; the former is 
the more likely explanation. 
Table 1 Socio-dem.ographic characteristics and bloodborne viral status 
of clients attending drug treatment centres 
in Dublin 24 and Dublin 8 in 2001 
Age in years 
29 or younger 
30 to 39 
40 or older 
Gender 
Male 
Months in treatment 
0 to 12 months 
13 to 24 months 
25 to 36 months 
37 months or more 
Tested for HIV virus 
Yes 
No 
Unknown 
Of those tested: 
Positive 
Negative 
Tested for hepatitis 
B surface antigen 
Yes 
No 
Unknown 
Of those tested: 
Positive 
Negative 
Tested for hepatitis 
C virus 
Yes 
No 
Unknown 
Of those tested: 
Positive 
Negative 
Dublin 24 Dublin 8 
Number (%, and 95% confidence 
intervals for positive test results) 
64 
53 (82.8) 
9 ( 1 4 1 ) 
2(3.1) 
64 
41 (64.1) 
64 
19(29.7) 
10(15.6) 
15(23.4) 
20(31.3) 
64 
55 (85.9) 
6 (9.4) 
3 (4.7) 
1 (1.8, 95% CI 
0.05-9.7) 
54 (98.2) 
64 
53 (82.8) 
7(10.9) 
4 (6.3) 
0 (0.0, 9 5 % 
CI 0.0-6.7) 
53(100.0) 
64 
58 (90.6) 
3 (4.7) 
3 (4.7) 
31 (53.4,95% 
CI 39.9-66.7) 
27 (46.6) 
101 
61 (60.4) 
33 (32.7) 
7 (6.9) 
101 
53 (52.5) 
101 
21 (20.8) 
33 (32.7) 
20(19.8) 
27 (26.7) 
101 
94(93.1) 
7 (6.9) 
0 (0.0) 
18(19.1,95% 
CI 11.8-28.6) 
76 (80.9) 
100 
80 (80.0) 
15(15.0) 
5 (5.0) 
1 (1.3,95% 
CI 0.03-6.8) 
79 (98.7) 
101 
92(91.1) 
7 (6.9) 
2 (2.0) 
67 (72.8, 95% 
CI 62.6-81.6) 
25 (27.2) 
p value 
<0.01 
0.1 
0.1 
0.1 
<0.01 
0.7 
1.0 
0.5 
0.02 
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1997-1999 
2000 
Ever previously treated for drug misuse (n=762) 
Never treated 
Previously treated 
Age (in years) at this treatment contact (n=800) 
19 or younger 
20 to 29 
30 to 39 
40 or older 
Gender (n=791) 
Male 
Female 
Regular employment (n=773) 
No 
Yes 
Cannabis cited as a problem drug (n=803) 
No 
Yes 
Cocaine cited as a problem drug (n=803) 
No 
Yes 
Used primary drug daily in the last month (n=773) 
No 
Yes 
Cannabis cited as a problem drug, by year treated 
(interaction) 
542 
261 
263 
499 
148 
483 
146 
23 
535 
256 
581 
192 
598 
205 
683 
120 
325 
448 
240 (44.3) 
62 (23.8) 
135(51.3) 
157(31.5) 
85 (57.4) 
181 (37.5) 
31 (21.2) 
5(27.1) 
212(39.6) 
88 (34.4) 
181 (31.2) 
116 (60.4) 
196(32.8) 
106(51.7) 
290 (42.5) 
12(10.0) 
177 (54.5) 
109 (24.3) 
302 (55.7) 
199(76.2) 
128(48.7) 
342 (68.5) 
63 (42.6) 
302 (62.5) 
115 (78.8) 
18(78.3) 
323 (60.4) 
168 (65.6) 
400 (68.8) 
76 (39.6) 
402 (67.2) 
99 (48.3) 
393 (57.5) 
108(90.0) 
148 (45.5) 
339 (75.7) 
1 
Interaction 
1 
1.8(1.2-2.7) 
1 
2.4(1.5-4.0) 
6.2(3.1-12.2) 
6.9(1.7-27.9) 
1 
1.9(1.3-2.9) 
1 
0.4 (0.2-0.6) 
1 
Interaction 
1 
5.7(2.8-11.6) 
1 
5.6 (3.7-8.4) 
<0.01 
< 0.0001 
< 0.0001 
<0.01 
0.001 
< 0.0001 
< 0.0001 
< 0.0001 
<0.01 
* The initial model also included the variables age, education status, benzodiazepines cited as a problem drug, injector status and age started injecting. 
t For the whole model D2 258.8 df 12 p < 0.00011 Numbers do not always add up to total as not all questions were answered. 
A much higher proportion of injectors living in Dublin 8 than in Dublin 24 
used heroin and cocaine concurrently, 18.0 per cent (76/423) versus 1.0 
per cent (2/201) respectively, p value < 0.0001. 
Level of education achieved was not associated with area of residence. 
Discussion 
The findings indicate that a higher proportion of heroin users in Dublin 
8 had HIV and hepatitis C than their counterparts in Dublin 24. They 
were five times more likely to report cocaine as a problem drug, three 
times more likely to report daily drug use, and more likely to be older than 
those who lived in Dublin 24. Of note, Dublin 8 is close to the city centre 
and may have a higher proportion of homeless people living in unstable 
accommodation in the area. It is generally accepted that homeless 
persons have more chaotic drug using problems and we were not able to 
control for this factor in the study. 
Although the study findings are limited because there were two unlinked 
samples, the demographic profile of the two samples by respective areas 
of residence was similar. The small sample size in Part 1 led to wide 
confidence intervals around the proportions with each of the infections; 
nevertheless, there was a clear difference between the two areas in the 
proportion testing positive for HIV. Because of resource limitations in Part 
1, the researchers did not ascertain the injector status of the respondents. 
In Part 2, there was an interaction between cannabis and year treated but 
this did not affect the more pertinent relationships reported. 
There is historical evidence that the prevalence of HIV is not uniformly 
distributed in geographical areas of Dublin. In 1994, O'Kelly and Bury9 
reviewed clinical records to estimate the proportion of heroin users in 
an electoral division in Dublin 8 who had acquired the HIV virus over 
a nine-year period. Of the 82 injecting drug users participating in the 
study, 53 (65%) tested positive for HiV between 1985 and 1994. 
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The authors noted that, while the overall prevalence of HIV infection 
among all injecting drug users in Dublin was around 15 per cent, their 
study population had an extremely high prevalence at 65 per cent. This 
indicates that this area may have had a larger pool of infected HIV cases 
in Dublin 8 than other areas of Dublin. We suggest that a case-control 
study be conducted to establish the exact relationship between HIV and 
area of residence. 
Correspondence: Jean Long 
Drug Misuse Research Division, Health Research Board, Holbrook 
House, Holies Street, Dublin 2 
Email: jlong@hrb.ie 
At the time of the Part 1 data collection, there were established needle-
exchange programmes in Dublin 8, whereas there were no such 
programmes in Dublin 24. Since 2001 two small community-based 
needle-exchange facilities have been established in Dublin 24. Despite 
the presence of needle exchanges in Dublin city, there is a long history 
of heroin users borrowing and lending injecting equipment. In 1997, 186 
injecting drug users who attended a drug treatment centre in Dublin 
reported several high-risk behaviours: 56 per cent shared needles, of 
whom 94 per cent reported cleaning their equipment, but less than 
half of them had done so effectively.10 In more recent studies, older 
injectors were more likely to test positive for HIV than their younger 
counterparts.I1-13 Length of injecting and needle-sharing status were 
also associated with testing positive for HIV among injectors entering 
Irish prisons.13 
Between December 2000 and October 2001, Corr14 evaluated the 
outreach service operated by the Health Promotion Unit of Merchants 
Quay Ireland (a large non-government organisation), located in Dublin 
8. The outreach workers reported that, among the 99 clients who were 
met more than once, almost one-fifth had changed to safer drug-using 
practices and half had adopted less safe practices. It may be useful to 
explore why half of those participating in the Merchants Quay Ireland 
study developed additional unsafe injecting practices despite receiving 
safe injecting information, as this may further explain our observations on 
the transmission of HIV in this area. 
In 2003, Merchants Quay lreland15explored cocaine use among those 
attending their Health Promotion Unit and found that cocaine use was 
common among attendees. The respondents reported high-risk practices 
associated with binge use of this drug. 
In the international setting, Millison and colleagues1 reported that 
the prevalence of HIV among injecting drug users recruited through 
needle-exchange programmes during 1997 and 1998 in nine Ontario 
cities ranged from 1.4 per cent to 14.7 per cent. Testing positive for 
HIV antibodies was associated with injecting drugs for more than five 
years, use of (powder) cocaine, use of crack, binge injecting (10 or more 
times per day at least once in the previous six months), and being a 
longer-term user of needle-exchange facilities. Other researchers have 
reported an association between binge cocaine use and testing positive 
for HIV.16'17 The findings of the present study also suggest differences 
in the prevalence of HIV by geographical area and its association with 
demographic characteristics and drug-using practices, particularly 
cocaine use. 
These findings led to a hypothesis: 'The risk of acquiring HIV and 
hepatitis C is associated with area of residence and may be linked 
to cocaine use'. This should be the subject of both qualitative and 
quantitative studies in order to identify the factors that lead to the 
excess risk among those living in Dublin 8 compared to Dublin 24 so 
that strategies may be developed to address them. The results of this 
study highlight the emerging cocaine problem and the high-risk practices 
associated with it. Our findings suggest that current harm reduction 
methods are not robust enough to prevent transmission of HIV among 
heroin users who also use cocaine. There is a clear need to ascertain 
which aspects of harm reduction are not effective and to determine what 
changes in harm reduction services are required to prevent transmission. 
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